IGM Biosciences, Inc.
IGMS
$1.28
$0.064.92%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -36.65M | -61.43M | -47.90M | -49.82M | -60.70M |
| Total Depreciation and Amortization | 2.35M | 2.31M | 2.28M | 2.18M | 2.18M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.30M | 17.14M | 9.15M | 8.21M | 11.15M |
| Change in Net Operating Assets | -6.83M | 3.60M | -896.00K | -2.98M | -643.00K |
| Cash from Operations | -34.82M | -38.39M | -37.37M | -42.42M | -48.01M |
| Capital Expenditure | -862.00K | -1.29M | -1.21M | -2.48M | -1.45M |
| Sale of Property, Plant, and Equipment | 0.00 | 7.00K | 32.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.86M | 14.27M | 25.71M | 11.14M | -13.25M |
| Cash from Investing | 18.00M | 12.99M | 24.52M | 8.65M | -14.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 420.00K | 1.20M | 647.00K | 192.00K | 402.00K |
| Repurchase of Common Stock | 0.00 | 0.00 | -1.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -31.00K | -40.00K | -- |
| Cash from Financing | 420.00K | 1.20M | 615.00K | 152.00K | 402.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.40M | -24.20M | -12.24M | -33.61M | -62.30M |